Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

BioMark Diagnostics Inc C.BUX

Alternate Symbol(s):  BMKDF

Healthcare Diagnostics & Research
Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer. The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of lung cancer, as well as glioblastoma (GBM), breast cancer, and head and neck cancer. It is also developing liquid biopsy tests for various cancer types, including glioblastoma, gastrointestinal, prostate, head, neck cancers. The company was incorporated in 2014 and is headquartered in Richmond, Canada.


CSE:BUX - Post by User

BioMark Diagnostics Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
  • PrussianfellowX
Post by Prussianfellowon Oct 18, 2021 4:54pm
212 Views
Post# 34019978

Positive News but virtually Zero Volume

Positive News but virtually Zero VolumeWhat is lacking here are some new investors with faith in Biomark success and willing to buy in.  Tiny insider buys are keeping this share price from free fall.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities